Clinical Trial

The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?

Study acronym: MS-ICU
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Here, the investigators propose to study host responses to reduced microbiome complexity driven by treatment with broad spectrum antibiotics in patients with severe infections or sepsis. The proposal aims to combine holistic approaches with emerging experimental technologies to investigate the complex interactions between the gut microbiota and its host and assess the impact of specific bacterial communities on longevity and stress responses. A strong focus of this study will also be placed on microbiome dysbiosis and secondary impacts on short- and long-term brain dysfunction using clinical, laboratory and imaging procedures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-23.
Status change: Not Yet Recruiting → Recruiting 2024-12-27
Trial Details
NCT Number NCT06749483
Lead Sponsor Jena University Hospital
Collaborators: University of Jena
Conditions Critical Illness, Intensive Care Unit Delirium, Neurocognitive Deficit, Microbiome,immune Function, Critically Ill, Infection in ICU, Sepsis
Enrollment 100 participants
Start Date 2024-12-27
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-30